Variantyx Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 43
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 3

Variantyx General Information


Developer of a whole genome sequencing platform intended to diagnose and generate clinical reports for rare inherited disorders. The company's platform simplifies sample collection, DNA extraction and sequencing, data analysis, interpretation and clinical reporting by automating them, enabling hospital and commercial labs to profitably expand their test menu with validated genomic diagnostic solutions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Decision/Risk Analysis
Primary Office
  • 1671 Worcester Road
  • Suite 300
  • Framingham, MA 01701
  • United States
+1 (617) 000-0000

Variantyx Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Variantyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - PPP 02-May-2020 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Jan-2019 000 000.00 0000 Completed Generating Revenue
1. Early Stage VC (Series A) $4.8M $4.8M 000.00 Completed Startup
To view Variantyx’s complete valuation and funding history, request access »

Variantyx Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Variantyx’s complete cap table history, request access »

Variantyx Executive Team (5)

Name Title Board Seat Contact Info
Haim Neerman Co-Founder & Chief Executive Officer
Tomer Jackman Co-Founder & Chief Operating Officer
Noam Shomron Ph.D Co-Founder & Chief Scientific Officer
Muthu Meyyappan Ph.D Chief Commercial Officer
Yaron Rachmany CIO
To view Variantyx’s complete executive team members history, request access »

Variantyx Board Members (4)

Name Representing Role Since
Gideon Argov Variantyx Board Member 000 0000
Greg Faust Variantyx Board Member 000 0000
Guy Ezekiel Ph.D Variantyx Board Member 000 0000
Hillel Bachrach Variantyx Board Member 000 0000
To view Variantyx’s complete board members history, request access »

Variantyx Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Variantyx Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
New Era Capital Partners Venture Capital Minority 000 0000 000000 0
Pitango Venture Capital Venture Capital Minority 000 0000 000000 0
20/20 HealthCare Partners Venture Capital Minority 000 0000 000000 0
To view Variantyx’s complete investors history, request access »